Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI); MITCI

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleIntratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI); MITCI
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsEric Whitman